Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer
Status:
Unknown status
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the role of metronomic cyclophosphamide in addition
to docetaxel in first line therapy in metastatic breast cancer.